These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28733260)

  • 1. Significant Hepatic Fibrosis Among Treatment-Naive Chronic Hepatitis B Virus With Increased Hepatitis B Virus DNA and Normal Alanine Aminotransferase.
    Wong RJ; Le A; Nguyen MT; Trinh HN; Huynh A; Ly MT; Nguyen HA; Nguyen KK; Yang J; Garcia RT; Levitt B; da Silveira E; Gish RG
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):146-148. PubMed ID: 28733260
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
    Xie Q; Hu X; Zhang Y; Jiang X; Li X; Li J
    J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and histopathological features of chronic hepatitis B virus infected patients with high HBV-DNA viral load and normal alanine aminotransferase level: A multicentre-based study in China.
    Xing YF; Zhou DQ; He JS; Wei CS; Zhong WC; Han ZY; Peng DT; Shao MM; Sham TT; Mok DK; Chan CO; Tong GD
    PLoS One; 2018; 13(9):e0203220. PubMed ID: 30180183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
    Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
    Tan YW; Zhou XB; Ye Y; He C; Ge GH
    World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spleen thickness can predict significant liver pathology in patients with chronic hepatitis B with persistently normal alanine aminotransferase or minimally raised alanine aminotransferase: a retrospective study.
    Zhang J; Du X; Zhou Z; Lv F; Yu Y
    J Int Med Res; 2019 Jan; 47(1):122-132. PubMed ID: 30213226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can quantitative hepatitis B surface antigen levels predict the severity of liver disease in genotype E Patients?
    Chakrabarty G; Bruce M; Horner M; Wang B; Agarwal K; Carey I
    J Viral Hepat; 2018 Jan; 25(1):80-87. PubMed ID: 28710798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of an outpatient chronic hepatitis B virus infection cohort.
    Assis DR; Tenore Sde B; Pinho JR; Lewi DS; Ferreira PR
    Einstein (Sao Paulo); 2015; 13(2):189-95. PubMed ID: 26154539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.
    Park JY; Park YN; Kim DY; Paik YH; Lee KS; Moon BS; Han KH; Chon CY; Ahn SH
    J Viral Hepat; 2008 Aug; 15(8):615-21. PubMed ID: 18573162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].
    Xu Y; Wang JB; Xu J; Jiao J; Zhang YG; Ji SW; Zhao P; Guo HH; Li Y; Zhou CY
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):109-12. PubMed ID: 20196949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin.
    Preda CM; Popescu CP; Baicus C; Constantinescu I; Oproiu A; Voiosu T; Diculescu M; Negreanu L; Gheorghe L; Sporea I; Trifan A; Ceausu E; Proca D; Manuc M
    J Viral Hepat; 2018 Jul; 25(7):834-841. PubMed ID: 29397016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of significant fibrosis in chronic hepatitis B patients with low viremia.
    Abdo AA; Bzeizi KI; Babatin MA; AlSohaibani F; AlMana H; Alsaad KO; AlGhamdi H; Al-Hamoudi W; AlSwat K; AlFaleh FZ; Myers RP; Sanai FM
    J Clin Gastroenterol; 2014 Jul; 48(6):e50-6. PubMed ID: 24072073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤ 40 IU/L and significant hepatic fibrosis.
    Chao DT; Lim JK; Ayoub WS; Nguyen LH; Nguyen MH
    Aliment Pharmacol Ther; 2014 Feb; 39(4):349-58. PubMed ID: 24387289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between HBV-DNA level and histology in patients with naive chronic HBV infection.
    Vardar R; Gunsar F; Sertoz R; Ozacar T; Nart D; Barbet FY; Karasu Z; Ersoz G; Akarca US
    Hepatogastroenterology; 2010; 57(101):908-12. PubMed ID: 21033250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.
    Alam S; Ahmad N; Mustafa G; Shrestha A; Alam AK; Khan M
    Liver Int; 2011 Jul; 31(6):824-30. PubMed ID: 21645213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
    Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
    Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.
    Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):227-33. PubMed ID: 19121647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection.
    Zhong YW; Di FL; Liu C; Zhang XC; Bi JF; Li YL; Wu SQ; Dong H; Liu LM; He J; Shi YM; Zhang HF; Zhang M
    Clin Microbiol Infect; 2016 Apr; 22(4):379.e1-379.e8. PubMed ID: 26577140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.
    Lesmana CR; Gani RA; Hasan I; Simadibrata M; Sulaiman AS; Pakasi LS; Budihusodo U; Krisnuhoni E; Lesmana LA
    J Dig Dis; 2011 Dec; 12(6):476-80. PubMed ID: 22118698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.